ArticleBMC veterinary research2026
Serological investigation of foot and mouth disease in cattle in East Bale Zone, Ethiopia.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFoot and mouth disease (FMD) is a highly contagious viral disease affecting cloven-hooved animals, including cattle, that reduces production and causes significant economic losses. Despite its importance, limited information about the epidemiology of FMD in East Bale Zone, Ethiopia.
methodsA cross-sectional study was conducted from December 2024 to June 2025 to estimate the seroprevalence of FMD, identify circulating serotypes, evaluate associated risk factors, and assess the community’s knowledge and perceptions of farmers regarding the disease. A total of 384 blood samples were randomly collected from cattle and screened for antibodies against FMDV-NSP using the 3ABC ELISA ID screen competition kit (ID-VET, Grabels, France). Twenty-two individual animal serum samples with strongly positive (competition percentage value < 20%) were further examined to determine the circulating FMDV serotypes using a solid-phase competitive ELISA (SPCE) commercially available kit (IZSLER, Brescia, Italy). In addition, a questionnaire survey was administered to 110 livestock owners to assess their knowledge, attitudes, and practices toward FMD. Data were analyzed using descriptive statistics and logistic regression to identify significant associations with FMD seropositivity.
resultsAn overall seroprevalence of 27.08% (95% CI: 22.88–31.74) was recorded. Multivariable logistic regression analysis revealed a significant association between seroprevalence and age, body condition, and herding practice. Adults (> 3 years) were 2.33 times more likely to be seropositive than younger cattle (OR = 2.33, 95% CI = 1.401–3.894; P = 0.001), and cattle with poor body condition had significantly higher seropositivity than those in good condition (OR = 2.32, 95% CI = 1.220–4.440; P = 0.010). Cattle kept with sheep and goats were 2.9 times more likely to be seropositive than cattle kept alone (OR = 2.9, 95% CI = 1.178–7.111; P = 0.020). The dominant circulating serotypes were SAT-2 (22.72%), O (18.18%), and SAT-1 (4.54%). Furthermore, mixed serotypes A and SAT-2, O and SAT-2, O, SAT-2 and SAT-1, and serotypes O, SAT-1, and SAT-2 were observed. Although 84.6% of respondents recognized FMD by its local name, “Okkolchiisaa,” their understanding of disease transmission and prevention practices was limited.
conclusionThe current investigation revealed that exposure to FMDV is widespread in East Bale Zone, with circulating serotypes O, SAT-1, SAT-2, and mixed serotypes. Therefore, the implementation of targeted trivalent vaccination and enhanced farmer education on FMD transmission and prevention is essential for effective disease management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.